ETFMG Alternative Harvest ETF – an exchange traded fund specializing mainly in Canadian cannabis companies and ancillary marijuana businesses – will begin to include U.S.-based marijuana multistate operators.
Omar Sacirbey
Omar Sacirbey's Latest Posts
DEA awards seventh cannabis cultivation license for research
Maridose has been licensed by the U.S Drug Enforcement Administration and Department of Justice for the bulk manufacture of cannabis to supply marijuana, MJ extracts (including isolated chemical constituents) and THC to researchers.
New Jersey adult-use cannabis sales reach nearly $80M in 2nd fiscal quarter
New Jersey adult-use cannabis businesses recorded nearly $79.7 million in total sales between April 21 and June 30 of the state’s second fiscal quarter.
How one high-end fashion brand sought to woo its fans with cannabis – and found a new audience in the process
Since high school, Brett Heyman sought out acrylic clutch purses from the 1950s and ’60s. But over time, they became harder to find. That’s when the former Gucci public relations manager saw an opportunity to reproduce the purses and sell them herself.
Schwazze marketing executive pinpoints brand identity
Julie Suntrup joined Schwazze, a vertically integrated cannabis business, in late 2020 as head of marketing and merchandising.
The Denver-based company was coming off a checkered acquisition spree and was in the middle of a sputtering rebrand.
Marketing pros advise brand differentiation, sharing story on multiple channels
From consumer sophistication to product choices, the cannabis market looks different than it did even a few years ago. And brand strategies that worked then might not cut it today.
So what does hit the mark when establishing a brand in today’s cannabis business?
Oklahoma group submits signatures for adult-use marijuana legalization
An Oklahoma group aiming to get an adult-use marijuana market legalized through a statewide vote in November submitted more than 164,000 signatures to the secretary of state.
Marijuana companies find increasing acceptance for therapeutic MJ research
Long restricted by the federal government and stigmatized by the medical and scientific communities, cannabis has been involved in only a handful of studies carried out in the United States over the past several decades.
Vireo partners with medical school to conduct pioneering cannabis research at a low cost
The goal of a cannabis research study doesn’t always have to be the creation of a drug approved by the U.S. Food and Drug Administration.
DEA licenses open new doors for marijuana-based therapeutic research
Six entities are registered with the DEA to cultivate marijuana for DEA-licensed researchers working on studies approved by the FDA.
CT Pharma uses FDA approval to provide cannabis for Yale University research studies
CT Pharma earned FDA approval to grow cannabis for Yale University, which is exploring the efficacy of cannabis to treat stress and pain.
Papa & Barkley leans on customer database to research marijuana product efficacy
Guy Rocourt, the CEO of Papa & Barkley, a California-based infused products maker, has followed cannabis research from his earliest days in the legal marijuana industry.
As the company’s former chief operating officer, Rocourt infused what he learned into the balms, edibles, tinctures and other products Papa & Barkley produces.
